Wednesday, May 13 @ 3:00 pm (EST)  |  The COVID-19 virus can stay infectious in the air for more than 12 hours, according to early research.

[link removed]
[link removed]
Is COVID-19 airborne? A Q & A with
Chad Roy, PhD and Ed Zuroweste, MD
Wednesday, May 13, 2020
12:00 PM (PST) / 3:00 PM (EST)
Register for Webinar ([link removed])
The virus behind the COVID-19 pandemic can stay infectious in the air for more than 12 hours, according to early research out of four major US laboratories. Scientists involved in this research warn that the airborne infectiousness of COVID-19 may have been underestimated by the World Health Organization. It is still unclear how much of the SARS-CoV-2 virus you would need to inhale to get sick, but researchers are finding that it is remarkably resilient in the air when aerosolized into smaller particles.

What does this mean for clinicians on the front lines? Do these findings change the recommendations clinicians make to patients? Please join MCN for a Q and A on this topic with Chad Roy, PhD a microbiologist and Director of the Infectious Disease Aerobiology and Biodefense research programs at Tulane University and Ed Zuroweste, MD, founding chief medical officer of Migrant Clinicians Network. Dr. Roy is a lead researcher on some the latest research studies on COVID-19. Dr. Zuroweste is a family physician who has cared for farmworkers and their families and has served as a special medical consultant to the WHO for infectious diseases.

Presenters
Chad Roy, PhD
Dr. Roy is a microbiologist and director of the infectious disease aerobiology and biodefense research programs at Tulane University’s National Primate Center. He has focused his career on respiratory health and the aerobiology of airborne infectious diseases; specifically, on gaining a better understanding of aerosol infection in the context of the development and application of preclinical disease models; the majority of efforts are directed in the use of the nonhuman primate for this purpose. He is currently engaged in COVID-19 research, including serving as principal investigator of a $10.3 million National Institutes of Health grant to evaluate the nation's most promising vaccines and treatments to combat the disease.

Ed Zuroweste, MD
Dr. Zuroweste has over 30 years of experience as a family physician focused on the care of underserved populations in the US. For 20 years, Dr. Zuroweste maintained a full-time clinical practice in Chambersburg, Pennsylvania, first in private practice and later as the Medical Director of a Migrant/ Community Health Center. Dr. Zuroweste is the Founding Medical Director of the Migrant Clinicians Network. He is the Tuberculosis Medical Consultant for the Pennsylvania Department of Health. He is an Adjunct Assistant Professor of Medicine at Johns Hopkins School of Medicine for an international health elective for medical students in Honduras. Dr. Zuroweste served as a special medical consultant for the Global Influenza Program of the World Health Organization to help limited resource hospitals and clinics address the H1N1 pandemic and was part of the WHO Ebola Response Team in Guinea and Sierra Leone where he trained physicians and nurses to prepare to work in Ebola treatment centers.
Register for Webinar ([link removed])
Connect with us!
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]
Having trouble? View this email in your browser ([link removed])

============================================================
Copyright © 2020 Migrant Clinicians Network, All rights reserved.
You are receiving this email because you signed up for the MCN mailing list.

Our mailing address is:
Migrant Clinicians Network
P.O. Box 164285
Austin, TX 78716
USA
** unsubscribe from this list ([link removed])
** update subscription preferences ([link removed])